Acute Exacerbation of Chronic Obstructive Pulmonary Disease Due to Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia: Clinical Features and Prognostic Factors

References

• Wang M, Earley M, Chen L, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis. 2022;22(3):401–412. doi:10.1016/S1473-3099(21)00399-6
   PubMed Web of Science ®Google Scholar
• Minerdi D, Loqui D, Sabbatini P. Monooxygenases and antibiotic resistance: a focus on carbapenems. Biology. 2023;12(10):1316. doi:10.3390/biology12101316
   PubMedGoogle Scholar
• Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67:S128–S134. doi:10.1093/cid/ciy657
   PubMed Web of Science ®Google Scholar
• Chen J, Ma H, Huang X, et al. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study. Antimicrob Resist Infect Control. 2022;11:161. doi:10.1186/s13756-022-01204-w
   PubMed Web of Science ®Google Scholar
• Lan P, Jiang Y, Zhou J, et al. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:26–34. doi:10.1016/j.jgar.2021.02.020
   PubMed Web of Science ®Google Scholar
• Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: gold executive summary. Eur Respir J. 2023;61:2300239. doi:10.1183/13993003.00239-2023
   PubMed Web of Science ®Google Scholar
• Song Y, Chen R, Zhan Q, et al. The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infection. Int J Chron Obstruct Pulmon Dis. 2016;11:535–542. doi:10.2147/COPD.S96541
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Kunadharaju R, Sethi S. Treatment of acute exacerbations in chronic obstructive pulmonary disease. Clin Chest Med. 2020;41:439–451. doi:10.1016/j.ccm.2020.06.008
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351. doi:10.1016/S0140-6736(11)60968-9
   PubMed Web of Science ®Google Scholar
• Lin SH, Kuo PH, Hsueh PR, et al. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology. 2007;12(1):81–87. doi:10.1111/j.1440-1843.2006.00999.x
   PubMed Web of Science ®Google Scholar
• Ma X, Cui J, Wang J, et al. Multicentre investigation of pathogenic bacteria and antibiotic resistance genes in Chinese patients with acute exacerbation of chronic obstructive pulmonary disease. J Int Med Res. 2015;43(5):699–710. doi:10.1177/0300060515587577
   PubMed Web of Science ®Google Scholar
• Rodrigo-Troyano A, Sibila O. The respiratory threat posed by multidrug resistant Gram-negative bacteria. Respirology. 2017;22(7):1288–1299. doi:10.1111/resp.13115
   PubMed Web of Science ®Google Scholar
• Esposito F, Cardoso B, Sellera FP, et al. Expansion of healthcare-associated hypervirulent KPC-2-producing Klebsiella pneumoniae ST11/KL64 beyond hospital settings. One Health. 2023;17:100594. doi:10.1016/j.onehlt.2023.100594
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Q, Yin Y, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE network. Antimicrob Agents Chemother. 2018;62(2):e01882–17. doi:10.1128/AAC.01882-17
   PubMed Web of Science ®Google Scholar
• Qian Y, Bi Y, Liu S, et al. Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis and a systematic review. Ann Palliat Med. 2021;10(7):7340–7350. doi:10.21037/apm-21-338
   PubMed Web of Science ®Google Scholar
• Gonçalves Barbosa LC, Silva ESJA, Bordoni GP, et al. Elevated mortality risk from CRKp associated with comorbidities: systematic review and meta-analysis. Antibiotics. 2022;11(7):874. doi:10.3390/antibiotics11070874
   Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Chen IR, Huang PH, Wu PF, et al. Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:326–330. doi:10.1016/j.jgar.2021.03.028
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi:10.1097/00003246-198510000-00009
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang J, Zhou W, et al. Risk factors and prognosis of carbapenem-resistant Klebsiella pneumoniae infections in respiratory intensive care unit: a retrospective study. Infect Drug Resist. 2021;14:3297–3305. doi:10.2147/IDR.S317233
   PubMed Web of Science ®Google Scholar
• Wei X, Ma Z, Yu N, et al. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:121–129. doi:10.2147/COPD.S152826
   PubMed Web of Science ®Google Scholar
• Yang X, Dong N, Chan EW, et al. Carbapenem resistance-encoding and virulence-encoding conjugative plasmids in Klebsiella pneumoniae. Trends Microbiol. 2021;29(1):65–83. doi:10.1016/j.tim.2020.04.012
   PubMed Web of Science ®Google Scholar
• Lou T, Du X, Zhang P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: a large multicentre case-control and cohort study. J Infect. 2022;84(5):637–647. doi:10.1016/j.jinf.2022.03.010
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yu S, Chen C, et al. Comprehensive surveillance and sampling reveal carbapenem-resistant organism spreading in tertiary hospitals in China. Infect Drug Resist. 2022;15:4563–4573. doi:10.2147/IDR.S367398
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Song N, Chen Y. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. J Glob Antimicrob Resist. 2020;21:306–313. doi:10.1016/j.jgar.2019.09.006
   PubMed Web of Science ®Google Scholar
• Zinellu A, Zinellu E, Mangoni AA, et al. Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future. Eur Respir Rev. 2022;31:220095. doi:10.1183/16000617.0095-2022
   PubMed Web of Science ®Google Scholar
• Liu M, Hu R, Jiang X, et al. Coagulation dysfunction in patients with AECOPD and its relation to infection and hypercapnia. J Clin Lab Anal. 2021;35:e23733. doi:10.1002/jcla.23733
   PubMed Web of Science ®Google Scholar
• Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents. 2020;55(1):105833. doi:10.1016/j.ijantimicag.2019.10.014
   PubMed Web of Science ®Google Scholar